Showing results (111-120 of 307) with videos related to
Sort By:
Pageof 31
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 28, 2023
Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson's DiseaseSalima Brillman, Pravin Khemani, Stuart H Isaacson, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 17, 2022
Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 PandemicShadi Ghourchian, Yasar A Torres-Yaghi, Stuart H Isaacson, et al.Clinical Neuropharmacology|August 3, 2005
Levetiracetam-induced parkinsonism in a Huntington disease patientTheresa A Zesiewicz, Juan Sanchez-Ramos, Kelly L Sullivan, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 25, 2019
Dyskinesia mattersM Angela Cenci, Sara Riggare, Rajesh Pahwa, et al.Current Treatment Options in Neurology|October 3, 2001
Diffuse Lewy Body DiseaseTheresa A. Zesiewicz, Matthew J. Baker, Peter B. Dunne, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2009
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's diseaseRobert A Hauser, Kelly E Lyons, Terry McClain, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 31, 2006
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's diseaseTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser, et al.Journal of Neurology|February 26, 2016
A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystoniaYi Han, Andrea L Stevens, Khashayar Dashtipour, et al.Journal of Movement Disorders|April 25, 2025
Safety and efficacy of istradefylline in Parkinson's disease patients with and without pre-existing dyskinesia: Pooled analysis of 8 randomized controlled trialsNobutaka Hattori, Lawrence Elmer, Stuart H Isaacson, et al.Neurology and Therapy|June 11, 2025
Long-Term Safety and Efficacy of Repeated Cycles of RimabotulinumtoxinB in the Treatment of Chronic Sialorrhea: Results of the OPTIMYST TrialRajesh Pahwa, Eric Molho, Mark Lew, et al.Pageof 31